Adequacy of Nutritional Intake in a Canadian Population of Patients with Crohn's Disease

Journal of the American Dietetic Association

Volumn 107, Issue 9, 2007, Pages 1575-1580

  Aghdassi, Elaheh ^a   Wendland, Barbara E ^a   Stapleton, Melanie ^a   Raman, Maitreyi ^a   Allard, Johane P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MINERAL; VITAMIN;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CANADA; CROHN DISEASE; CROSS-SECTIONAL STUDY; DIET; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD; NUTRITION; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; STANDARD;

ADULT; BODY MASS INDEX; CANADA; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DIET; DIET RECORDS; DIETARY SUPPLEMENTS; ENERGY INTAKE; FEMALE; HUMANS; MALE; MINERALS; NUTRITION PHYSIOLOGY; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; SEVERITY OF ILLNESS INDEX; VITAMINS;

EID: 34548120904     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2007.06.011     Document Type: Article

References (62)

1. Gassull M.A., Abad A., Cabre E., Gonzalez-Huix F., Gine J.J., and Dolz C. Enteral nutrition in inflammatory bowel disease. Gut 27 (1986) 76-80
2. Han P.D., Burke A., Baldassano R.N., Rombeau J., and Lichtenstein G.R. Nutrition and inflammatory bowel disease. Gastroenterol Clin. 28 (1999) 423-436
3. Gee M.I., Grace M.G., Wensel R.H., Sherbaniuk R., and Thomson A.B. Protein-energy malnutrition in gastroenterology outpatients: Increased risk in Crohn's disease. J Am Diet Assoc. 85 (1985) 1466-1474
4. Rigaud D., Angel L.A., Cerf M., Carduner M.J., Melchior J.C., Sautier C., Rene E., Apfelbaum M., and Mignon M. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr. 60 (1994) 775-781
5. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 65 (1997) 564-567
6. Geerling B.J., Badart-Smook A., Stockbrugger R.W., and Brummer R.J. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 67 (1998) 919-926
7. Wendland B.E., Aghdassi E., Tam C., Carrier J., Steinhart A.H., Wolman S.L., Baron D., and Allard J.P. Lipid peroxidation and plasma antioxidant micronutrients in Crohn's disease. Am J Clin Nutr. 74 (2001) 259-264
8. Filippi J., Al-Jaouni R., Wiroth J.B., Hebuterne X., and Schneider S.M. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis. 12 (2006) 185-191
9. Dieleman L.A., and Heizer W.D. Nutritional issues in inflammatory bowel disease. Gastroenterol Clin N Am. 27 (1998) 435-451
10. Duerksen D.R., Nehra V., Bistrian B.R., and Blackburn G.L. Appropriate nutritional support in acute and complicated Crohn's disease. Nutrition 14 (1998) 462-465
11. Fernandez-Banares F., Abad-Lacruz A., Xiol X., Gine J.J., Dolz C., Cabre E., Esteve M., Gonzalez-Huix F., and Gassull M.A. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 84 (1989) 744-748
12. Fernández-Bañares F., Mingorance M.D., Esteve M., Cabre E., Lachica M., Abad-Lacruz A., Gil A., Humbert P., Boix J., and Gassull M.A. Serum zinc, copper and selenium levels in inflammatory bowel disease. Am J Gastroenterol. 85 (1990) 1584-1589
13. Abad-Lacruz A., Fernandez-Banares F., Cabre E., Gil A., Esteve M., Gonzalez-Huix F., Xiol X., and Gassull M.A. The effect of total enteral tube feeding on the vitamin status of malnourished patients with inflammatory bowel disease. Int J Vit Nutr Res. 58 (1988) 428-435
14. Griffiths A.M. Inflammatory bowel disease. Nutrition 14 (1998) 788-791
15. Miralles-Barrachina O., Savoye G., Belmonte-Zalar L., Hochain P., Ducrotte P., Hecketsweiler B., Lerebours E., and Dechelotte P. Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: The role of malnutrition. Clin Nutr. 18 (1999) 313-317
16. Fernández-Bañares F. Papel de los metabolitos de oxígeno reactivos en la patogenia de la enfermedad inflamatoria intestinal. Gastroenterol Hepatol. 18 (1995) 526-532
17. Lashner B.A., Provencher K.S., Seidner D.L., Knesebeck A., and Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112 (1997) 29-32
18. Aghdassi E., Wendland B.E., Steinhart A.H., Wolman S.L., Jeejeebhoy K.N., and Allard J.P. Randomized controlled trial of antioxidant vitamins: Effects on oxidative stress in patients with Crohn's disease. Am J Gastroenterol. 98 (2003) 348-353
19. Stokes M.A., and Hill G.L. Total energy expenditure in patients with Crohn's disease: Measurement by the combined body scan technique. JPEN 17 (1993) 3-7
20. Gee M.I., Grace M.G., Wensel R.H., Sherbaniuk R.W., and Thomson A.B. Nutritional status of gastroenterology outpatients: Comparison of inflammatory bowel disease with functional disorders. Am J Diet Assoc. 85 (1985) 1591-1599
21. Bannerman E., Davidson I., Conway C., Culley D., Aldhous M.C., and Ghosh S. Altered subjective appetite parameters in Crohn's disease patients. Clin Nutr. 20 (2001) 399-405
22. Best W.R., Becktel J.M., and Singleton J.W. Development of Crohn's disease activity index. Gastroenterology 70 (1976) 439-444
23. Food and Agriculture Organization. Report of a Joint FAO/WHO consultation Nicosia Cyprus, Nutrition Programme-WHO-Geneva. Methods of Monitoring Food & Nutrient Intake: Preparation and Use of Food-Based Dietary Guidelines. Available at: http://www.fao.org/DOCREP/x0243e/x0243e05.htm. Accessed July 15, 2005.
24. Millen B., and Morgan J.L. The 2D Food Portion Visual (1996), Nutrition Consulting Enterprises, Framingham, MA
25. Trumbo P., Schlicker S., and Poos M. Dietary reference intakes: Vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, manganese, molybdenum, nickel, silicon, vanadium and zinc. J Am Diet Assoc. 101 (2001) 294-301
26. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (2000), National Academies Press, Washington, DC
27. Best W.R., Becktel J.M., and Singleton J.W. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 77 (1979) 843-846
28. Summers R.W., Switz D.M., Sessions Jr. J.T., Becktel J.M., Best W.R., Kern Jr. F., and Singleton J.W. National Co-operative Crohn's Disease Study: Results of drug treatment. Gastroenterology 77 (1979) 847-869
29. Sakamoto N., Kono S., Wakai K., Fukuda Y., Satomi M., Shimoyama T., Inaba Y., Miyake Y., Sasaki S., Okamoto K., Kobashi G., Washio M., Yokoyama T., Date C., and Tanaka H. Epidemiology Group of the Research Committee on Inflammatory Bowel Disease in Japan. Dietary risk factors for inflammatory bowel disease: A multicenter case-control study in Japan. Inflamm Bowel Dis. 11 (2005) 154-163
30. Reif S., Klein I., Lubin F., Farbstein M., Hallak A., and Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 40 (1997) 754-760
31. Persson P.G., Ahlbom A., and Hellers G. Diet and inflammatory bowel disease: A case-control study. Epidemiology 3 (1992) 47-52
32. Kono S. Dietary and other risk factors of ulcerative colitis: A case-control study in Japan; Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Clin Gastroenterol. 19 (1994) 166-171
33. Mayberry J.F., Rhodes J., Allan R., Newcombe R.G., Regan G.M., Chamberlain L.M., and Wragg K.G. Diet in Crohn's disease: Two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci. 26 (1981) 444-448
34. Russel M.G., Engels L.G., Muris J.W., Limonard C.B., Volovics A., Brummer R.J., and Stockbrugger R.W. Modern life in the epidemiology of inflammatory bowel disease: A case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol. 10 (1998) 243-249
35. Mahmud N., and Weir D.G. The urban diet and Crohn's disease: Is there a relationship?. Eur J Gastroenterol Hepatol. 13 (2001) 93-95
36. Roediger W.E. A new hypothesis for the aetiology of Crohn's disease: Evidence from lipid metabolism and intestinal tuberculosis. Postgrad Med J. 67 (1991) 666-671
37. Roediger W.E., Giles A., Kaczmar A., and Ali S. Does exclusion of enteral lipid assist remission in Crohn's disease?. J Clin Gastroenterol. 17 (1993) 38-41
38. Endres S. Messengers and mediators: Interactions among lipids, eicosanoids and cytokines. Am J Clin Nutr. 57 (1993) 798S-800S
39. De Caterina R., and Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipid 31 (1996) S57-S63
40. De Caterina R., Cybulsky M.I., Clinton S.K., Gimbrone Jr. M.A., and Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 14 (1994) 1829-1836
41. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese III J., Spur B.W., Robinson D.R., Corey E.J., Lewis R.A., and Austen K.F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vivo neutrophil and monocyte leucotriene generation and neutrophil function. N Engl J Med. 312 (1985) 1217-1224
42. Miles E.A., and Calder P.C. Modulation of immune function by dietary fatty acids. Proc Nutr Soc. 57 (1998) 277-292
43. Sanderson P., and Calder P.C. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 94 (1998) 79-87
44. Karsten S., Schäfer G., and Schauder P. Cytokine production and DNA synthesis by human peripheral lymphocytes in response to palmitic, stearic, oleic, and linoleic acid. J Cell Physiol. 161 (1994) 15-22
45. Chen L.H., and Zhao Y. Eicosapentaenoic acid suppresses lipopolysaccharide-induced tumor necrosis factor-α expression by decreasing activation of activator protein-1. Am J Clin Nutr. 75 (2002) 366S
46. Yaqoob P., Knapper J.A., Webb D.H., Williams C.M., Newsholme E.A., and Calder P.C. Effect of olive oil on immune function in middle aged men. Am J Clin Nutr. 67 (1998) 129-136
47. Levy E., Rizwan Y., Thibault L., Lepage G., Brunet S., Bouthillier L., and Seidman E. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn's disease. Am J Clin Nutr. 71 (2000) 807-815
48. 6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: Role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 98 (2003) 112-117
49. Malinow M.R., Duell P.B., Williams M.A., Kruger W.D., Evans A.A., Anderson P.H., Block P.C., Hess D.L., Upson B.M., Graf E.E., Irvin-Jones A., and Wang L. Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocysteine concentrations. Lipids 36 (2001) S27-S32
50. den Heijer M., Koster T., Blom H.J., Bos G.M., Briet E., Reitsma P.H., Vandenbroucke J.P., and Rosendaal F.R. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 334 (1996) 759-762
51. Chowers Y., Sela B.A., Holland R., Fidder H., Simoni F.B., and Bar-Meir S. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol. 95 (2000) 3498-3502
52. Romagnuolo J., Fedorak R.N., and Dias V.C. Hyperhomocysteinemia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study. Am J Gastroenterol. 96 (2001) 2143-2149
53. Hoffenberg E.J., Deutsch J., Smith S., and Sokol R.J. Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr. 65 (1997) 1482-1488
54. D'Odorico A., Bortolan S., Cardin R., D'Inca R., Martines D., Ferronato A., and Sturniolo G.C. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol. 36 (2001) 1289-1294
55. Bjarnason I., Macpherson A., MacKintosh C., Buxton-Thomas M., Forgacs I., and Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 40 (1997) 228-233
56. Bernstein C.N., Blanchard J.F., Leslie W., Wajda A., and Yu B.N. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 133 (2000) 795-799
57. Jahnsen J., Falch J.A., Mowinckel P., and Aadland E. Body composition in patients with inflammatory bowel disease: A population-based study. Am J Gastroenterol. 98 (2003) 1556-1562
58. Bernstein C.N., Seeger L.L., Anton P.A., Artinian L., Geffrey S., Goodman W., Belin T.R., and Shanahan F. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study. Aliment Pharmacol Ther. 10 (1996) 777-786
59. Siffledeen J.S., Fedorak R.N., Siminoski K., Jen H., Vaudan E., Abraham N., Steinhart H., and Greenberg G. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease. Clin Gastroenterol Hepatol. 3 (2005) 122-132
60. Jorgensen L.M., Isaksson B., and Schroll M. Reproducibility and validity of 7-day food records. Eur J Clin Nutr. 46 (1992) 729-734
61. Stuff J.E., Garza C., Smith E.O., Nichols B.L., and Montandon C.M. A comparison of dietary methods in nutritional studies. Am J Clin Nutr. 37 (1983) 300-306
62. Imes S., Pinchbeck B.R., and Thomson A.B. Diet counselling modifies nutrient intake of patients with Crohn's disease. J Am Diet Assoc. 87 (1987) 457-462